| Financial Year |
March 31 2023 |
| Monetary Funds |
1,188,495,653.01 |
| Held-for-trading Financial Assets |
860,950,000.00 |
| Notes Receivable |
423,978,869.11 |
| Accounts Receivable |
1,026,537,989.27 |
| Advances to Suppliers |
29,019,025.98 |
| Other Receivables |
40,142,971.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
850,416.43 |
| Dividend Receivable |
-- |
| Inventories |
705,493,761.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,819,234.87 |
| Total Current Assets |
4,297,794,666.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,501,688.83 |
| Investment Properties |
-- |
| Fixed Assetes |
1,281,850,268.33 |
| Under-construction Projects |
74,022,459.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
321,224,615.08 |
| R&D expenses |
-- |
| Goodwill |
103,751,692.39 |
| Long-Term Deferred and Prepaid Expenses |
53,954,062.80 |
| Deferred Income Tax Assets |
135,076,860.58 |
| Other Non-Current Assets |
6,512,141.20 |
| Sub-Total of Non-Current Assets |
2,149,994,419.21 |
| Total Assets |
6,447,789,085.99 |
| Short-Term Loans |
162,774,434.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,169,687,691.77 |
| Accounts Payable |
525,123,014.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
70,336,330.63 |
| Taxes Payable |
48,469,846.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,971,422.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,981,987.83 |
| Other Current Liabilities |
417,415,524.24 |
| Sub-Total of Current Liabilities |
2,853,394,223.21 |
| Long-term Loans |
49,046,413.91 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
450,780.40 |
| Deferred Income Tax Liabilities |
11,491,138.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
98,260,131.76 |
| Total Liabilities |
2,951,654,354.97 |
| Paid-In Capital(Or Share Stock) |
847,653,618.00 |
| Capital Surplus |
22,532,146.71 |
| Surplus Reserve |
287,928,021.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,235,086,125.88 |
| Minority Stockholder's Interest |
102,934,819.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,393,199,911.99 |
| Owner's Equity（Stockholder's Equity） |
3,496,134,731.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,447,789,085.99 |
